PET 방사성 트레이서 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2033년)

PET Radioactive Tracers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2033

US $ 4,995 ￦ 6,876,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,043,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 11,695,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

Persistence Market Research는 최근 세계 PET 방사성 트레이서 시장에 대한 종합적인 보고서를 발표했습니다. 이 상세한 분석은 촉진요인, 동향, 기회, 도전 과제를 포함한 시장 역학에 대한 중요한 인사이트를 제공하고 시장 구조에 대한 완전한 이해를 제공합니다.

주요 인사이트

• PET 방사성 트레이서 시장 규모(2024년) : 10억 5,390만 달러
• 예상 시장 가치(2033년) : 19억 2,630만 달러
• 세계 시장 성장률(2024-2033년 CAGR) : 6.9%

PET 방사성 트레이서 시장 : 조사 범위

PET 방사성 트레이서 시장은 양전자단층촬영(PET) 영상에서 다양한 질병을 감지하고 모니터링하는 데 사용되는 다양한 제품을 포괄합니다. 이 시장에는 플루오르데옥시글루코스(FDG), 암모니아, 콜린 등 정확한 영상 진단에 필수적인 다양한 종류의 PET 방사성 트레이서가 포함됩니다. 이 시장은 병원, 영상 진단센터, 연구기관 등 다양한 부문을 대상으로 하며, 직판, 온라인 플랫폼, 의료용품 판매 대리점 등 다양한 채널을 통해 유통되고 있습니다. 영상 기술의 발전, 만성 질환의 증가, 질병 조기 발견 및 개인 맞춤형 의료에 대한 수요 증가가 성장 동력이 되고 있습니다.

시장 성장 촉진요인:

세계 PET 방사성 트레이서 시장의 성장에는 여러 가지 요인이 기여하고 있으며, PET 영상 및 방사성 트레이서 개발의 기술 발전은 진단 능력과 정확도를 향상시킵니다. 암, 심혈관질환, 신경 질환과 같은 만성 질환의 유병률 증가는 조기 진단 및 치료 모니터링을 위한 PET 영상에 대한 수요를 촉진합니다. 또한, 개인 맞춤형 의료와 정밀 진단에 대한 관심이 높아지면서 PET 방사성 트레이서의 채택이 증가하고 있습니다. 의료 인프라 및 R&D에 대한 투자 증가도 시장 확대를 촉진하고 있습니다.

시장 억제요인:

PET 방사성 트레이서 시장은 성장 잠재력에도 불구하고 PET 이미징 및 방사성 트레이서 비용이 높다는 문제에 직면해 있습니다. 규제 제약과 방사성 물질에 대한 엄격한 안전 기준은 시장 운영을 복잡하게 만들고 있습니다. 또한 PET 영상 처리에 필요한 전문 인프라와 숙련된 인력이 필요하다는 점도 시장에 영향을 미치고 있습니다. 대체 이미징 기술과의 경쟁과 분자 이미징의 발전도 시장 성장에 도전이 될 수 있습니다. 이러한 문제를 해결하기 위해서는 비용 절감, 규제 준수 및 지속적인 기술 혁신에 초점을 맞춰야 합니다.

시장 기회:

PET 방사성 트레이서 시장은 정밀의료 트렌드와 이미징 기술의 발전으로 인해 큰 비즈니스 기회를 제공하고 있습니다. 진단 능력을 강화한 새로운 방사성 트레이서의 시장 개척은 시장 확대의 잠재력을 가지고 있습니다. 만성질환의 증가와 고령화로 인해 PET 영상 서비스에 대한 수요가 증가하고 있습니다. 신흥시장 진출, 원격의료와 원격 진단의 성장은 새로운 성장의 길을 열어줄 것입니다. 전략적 파트너십, R&D 투자, 혁신적인 추적자 제제 채택은 새로운 기회를 활용하고 시장 리더십을 유지하기 위해 필수적입니다.

본 보고서에서 다루는 주요 질문들

• PET 방사성 트레이서 시장의 세계 성장을 촉진하는 주요 요인은 무엇인가?
• PET 방사성 트레이서의 종류와 용도는 다양한 진단 현장에서 어떤 종류와 용도를 채택하고 있는가?
• 기술 발전은 PET 방사성 트레이서 시장의 경쟁 상황에 어떤 영향을 미쳤습니까?
• PET 방사성 트레이서 시장의 주요 기업은 어디에 있으며, 경쟁력을 유지하기 위해 어떤 전략을 채택하고 있는가?
• 세계 PET 방사성 트레이서 시장의 새로운 동향과 향후 전망은?

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장 정의/범위/제한
• 포함 사항·제외 사항

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 혁신/개발 동향

제4장 주요 성공요인

• PET 스캐너 설치대수 시나리오
• PET 스캔 수 : 국가별
• 질병 역학
• 제품 채용/사용 상황 분석
• 규제 승인 경로
• 상환 시나리오
• 기술의 진보
• 적정 제조 규범(cGMP)
• 밸류체인 분석
• 품질 기준/인증
• PESTEL 분석
• Porters 분석

제5장 시장 배경

• 거시경제 요인
• 예측요인 - 관련성과 영향
• 시장 역학

제6장 COVID-19 위기 분석

• 2024년 시장 시나리오
• COVID-19와 영향 분석
  • 제품별
  • 용도별
  • 최종사용자별
  • 지역별

제7장 세계 시장 수요(금액 또는 규모, 백만 달러) 분석

• 과거 시장 금액(백만 달러) 분석, 2019-2023년
• 현재 및 향후 시장 금액(백만 달러) 예측, 2024-2033년
  • 전년비 성장 동향 분석
  • 절대액 기회 분석

제8장 세계 시장 분석 : 제품별

• 소개/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 제품별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 제품별, 2024-2033년
  • F-18
  • C-11
  • Ga-68
  • O-15
  • N-13
  • Cu-64
• 시장 매력 분석 : 최종사용자별

제9장 세계 시장 분석 : 용도별

• 소개/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 용도별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 용도별, 2024-2033년
  • 신경질환
  • 암 진단과 예후
  • 심장 기능 장애
  • 감염증 진단
  • 기타
• 시장 매력 분석 : 용도별

제10장 세계 시장 분석 : 최종사용자별

• 소개/주요 조사 결과
• 과거 시장 규모(백만 달러) 분석 : 최종사용자별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 최종사용자별, 2024-2033년
  • 병원
  • 전문 진단 센터
  • 암 연구 센터
  • 학술조사기관
• 시장 매력 분석 : 최종사용자별

제11장 세계 시장 분석 : 지역별

• 소개
• 과거 시장 규모(백만 달러) 분석 : 지역별, 2019-2023년
• 현재 및 향후 시장 규모(백만 달러) 분석과 예측 : 지역별, 2024-2033년
  • 북미
  • 라틴아메리카
  • 동아시아
  • 남아시아 및 태평양
  • 서유럽
  • 동유럽
  • 중앙아시아
  • 러시아 및 벨라루스
  • 발칸반도 및 발트 국가
  • 중동 및 아프리카
• 시장 매력 분석 : 지역별

제12장 북미 시장 분석

제13장 라틴아메리카 시장 분석

제14장 동아시아 시장 분석

제15장 남아시아 및 태평양 시장 분석

제16장 서유럽 시장 분석

제17장 동유럽 시장 분석

제18장 중앙아시아 시장 분석

제19장 러시아 및 벨라루스 시장 분석

제20장 발칸반도 및 발트 국가 시장 분석

제21장 중동 및 아프리카(MEA) 시장 분석

제22장 시장 구조 분석

• 시장 분석 : 기업 계층별
• 주요 기업의 시장 점유율 분석
• 시장 입지 분석

제23장 경쟁 분석

• 경쟁 대시보드
• 경쟁 벤치마크
• 경쟁 상세 정보
  • Eli Lilly and Company
  • Blue Earth Diagnostics
  • Lantheus
  • Siemens Healthcare Private Limited
  • GE Healthcare
  • Advanced Accelerator Applications(Novartis)
  • University of Lowa HealthCare
  • Telix Pharmaceuticals Limited
  • Jubilant Radiopharma
  • TRASIS
  • RadioMedix Inc.
  • IBA Radiopharma Solutions
  • Piramal Imaging(Life Molecular Imaging)
  • Cardinal Health
  • DuchemBio, Co., Ltd

제24장 사용되는 가정과 두문자어

제25장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global PET Radioactive Tracers Market. This detailed analysis provides critical insights into the market dynamics, including drivers, trends, opportunities, and challenges, offering a thorough understanding of the market structure.

Key Insights:

• PET Radioactive Tracers Market Size (2024E): USD 1,053.9 Million
• Projected Market Value (2033F): USD 1,926.30 Million
• Global Market Growth Rate (CAGR 2024 to 2033): 6.9%

PET Radioactive Tracers Market - Report Scope:

The PET Radioactive Tracers Market covers a range of products utilized in positron emission tomography (PET) imaging to detect and monitor various diseases. This market includes different types of PET radioactive tracers, such as fluorodeoxyglucose (FDG), ammonia, and choline, essential for accurate diagnostic imaging. The market caters to diverse segments including hospitals, diagnostic imaging centers, and research institutions, distributed through channels like direct sales, online platforms, and medical supply distributors. Growth is driven by advancements in imaging technology, increasing prevalence of chronic diseases, and rising demand for early disease detection and personalized medicine.

Market Growth Drivers:

Several factors contribute to the growth of the global PET Radioactive Tracers Market. Technological advancements in PET imaging and radioactive tracer development enhance diagnostic capabilities and accuracy. The increasing prevalence of chronic diseases such as cancer, cardiovascular disorders, and neurological conditions drives the demand for PET imaging for early diagnosis and treatment monitoring. Furthermore, the rising focus on personalized medicine and precision diagnostics boosts the adoption of PET radioactive tracers. Increased investments in healthcare infrastructure and research and development also fuel market expansion.

Market Restraints:

Despite its growth potential, the PET Radioactive Tracers Market faces challenges related to the high cost of PET imaging and radioactive tracers, which can limit their accessibility and adoption. Regulatory constraints and stringent safety standards for radioactive materials add complexity to market operations. Additionally, the market is impacted by the need for specialized infrastructure and trained personnel for PET imaging procedures. Competition from alternative imaging techniques and advancements in molecular imaging may also pose challenges to market growth. Addressing these issues requires a focus on cost reduction, regulatory compliance, and ongoing innovation.

Market Opportunities:

The PET Radioactive Tracers Market presents significant opportunities driven by the growing trend of precision medicine and advancements in imaging technologies. The development of new and improved radioactive tracers with enhanced diagnostic capabilities offers potential for market expansion. The rising prevalence of chronic diseases and an aging population increase the demand for PET imaging services. Expansion into emerging markets and the growth of telemedicine and remote diagnostics present new avenues for growth. Strategic partnerships, investments in R&D, and the introduction of innovative tracer formulations are essential for capitalizing on emerging opportunities and maintaining market leadership.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the PET Radioactive Tracers Market globally?
• Which types and applications of PET radioactive tracers are leading the adoption in various diagnostic settings?
• How are technological advancements influencing the competitive landscape of the PET Radioactive Tracers Market?
• Who are the key players in the PET Radioactive Tracers Market, and what strategies are they employing to stay competitive?
• What are the emerging trends and future prospects in the global PET Radioactive Tracers Market?

Competitive Intelligence and Business Strategy:

Leading players in the global PET Radioactive Tracers Market, including GE Healthcare, Siemens Healthineers, and Philips Healthcare, focus on innovation, product differentiation, and strategic collaborations to gain a competitive edge. These companies invest in R&D to develop advanced radioactive tracers and imaging technologies, such as PET-CT and PET-MRI systems. Collaborations with research institutions, hospitals, and diagnostic centers facilitate market access and promote new product adoption. Emphasis on regulatory compliance, high-quality products, and comprehensive marketing strategies fosters market growth and enhances brand loyalty in the evolving PET Radioactive Tracers Market landscape.

Key Companies Profiled:

• Eli Lilly and Company
• Blue Earth Diagnostics
• Lantheus
• Siemens Healthcare Private Limited
• GE Healthcare
• Advanced Accelerator Applications (Novartis)
• University of Lowa HealthCare
• Telix Pharmaceuticals Limited
• Jubilant Radiopharma
• TRASIS
• RadioMedix Inc.
• IBA Radiopharma Solutions
• Piramal Imaging (Life Molecular Imaging)
• Cardinal Health
• DuchemBio, Co. Ltd.

PET Radioactive Tracers Market Industry Segmentation

By Product Type:

• F-18
• C-11
• Ga-68
• O-15
• N-13
• Cu-64

By Applications

• Neurological Disorders
• Cancer Diagnosis & Prognosis
• Cardiac Dysfunctions
• Infectious Disease Diagnosis
• Others

By End User:

• Hospitals
• Speciality Diagnostic Centers
• Cancer Research Centers
• Academic & Research Institutes

By Region:

• North America
• Latin America
• East Asia
• South Asia & Pacific
• Western Europe
• Eastern Europe
• Central Asia
• Russia & Belarus
• Balkan & Baltic Countries
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusion and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Innovation / Development Trends

4. Key Success Factors

• 4.1. PET Scanner Installed Base Scenario
• 4.2. Number of PET Scans, By Country
• 4.3. Disease Epidemiology
• 4.4. Product Adoption/Usage Analysis
• 4.5. Regulatory Approval Pathway
• 4.6. Reimbursement Scenario
• 4.7. Technology Advancements
• 4.8. Good Manufacturing Practice (cGMP)
• 4.9. Value Chain Analysis
• 4.10. Quality Standards/Accreditations
• 4.11. PESTEL Analysis
• 4.12. Porter's Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Outlook
  • 5.1.2. Global Healthcare Expenditure Outlook
  • 5.1.3. Oncology Spending
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Development of Novel Products
  • 5.2.2. Regulatory Imposition
  • 5.2.3. Increasing Spending on Targeted Therapies
  • 5.2.4. Increasing Prevalence of Cancer
  • 5.2.5. Strategic Mergers and Acquisitions among Local Players
  • 5.2.6. Rising Awareness towards Development of Disease
• 5.3. Market Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. 2024 Market Scenario
• 6.2. COVID-19 and Impact Analysis
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Region

7. Global Market Demand (in Value or Size in US$ Mn) Analysis 2019-2023 and Forecast, 2024-2033

• 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2023
• 7.2. Current and Future Market Value (US$ Mn) Projections, 2024-2033
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) Analysis By Product, 2019-2023
• 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product, 2024-2033
  • 8.3.1. F-18
    • 8.3.1.1. Florbetapir
    • 8.3.1.2. Florbetaben
    • 8.3.1.3. Flutemetamol
    • 8.3.1.4. Fludeoxyglucose
    • 8.3.1.5. Sodium Fluoride
    • 8.3.1.6. Others
  • 8.3.2. C-11
    • 8.3.2.1. Choline
    • 8.3.2.2. Methionine
    • 8.3.2.3. Others
  • 8.3.3. Ga-68
    • 8.3.3.1. DOTA-TOC
    • 8.3.3.2. DOTATATE
    • 8.3.3.3. DOTANOC
    • 8.3.3.4. Others
  • 8.3.4. O-15
  • 8.3.5. N-13
  • 8.3.6. Cu-64
• 8.4. Market Attractiveness Analysis By End User

9. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Application

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis By Application, 2019-2023
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Application, 2024-2033
  • 9.3.1. Neurological Disorders
    • 9.3.1.1. Alzheimer's Disease
    • 9.3.1.2. Dementia
    • 9.3.1.3. Others
  • 9.3.2. Cancer Diagnosis & Prognosis
    • 9.3.2.1. Solid Tumor
    • 9.3.2.2. Hematology Tumor
  • 9.3.3. Cardiac Dysfunctions
    • 9.3.3.1. Myocardial Infarction
    • 9.3.3.2. Others
  • 9.3.4. Infectious disease Diagnosis
  • 9.3.5. Others
• 9.4. Market Attractiveness Analysis By Application

10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By End User

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2023
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2024-2033
  • 10.3.1. Hospitals
  • 10.3.2. Speciality Diagnostic Centers
  • 10.3.3. Cancer Research Centers
  • 10.3.4. Academic & Research Institutes
• 10.4. Market Attractiveness Analysis By End User

11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2023
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2033
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. East Asia
  • 11.3.4. South Asia & Pacific
  • 11.3.5. Western Europe
  • 11.3.6. Eastern Europe
  • 11.3.7. Central Asia
  • 11.3.8. Russia & Belarus
  • 11.3.9. Balkan & Baltic Countries
  • 11.3.10. Middle East & Africa
• 11.4. Market Attractiveness Analysis By Region

12. North America Market Analysis 2019-2023 and Forecast 2024-2033

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 12.3.1. By Country
    • 12.3.1.1. U.S.
    • 12.3.1.2. Canada
  • 12.3.2. By Product
  • 12.3.3. By Application
  • 12.3.4. By End User
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Product
  • 12.4.3. By Application
  • 12.4.4. By End User
• 12.5. Key Market Trends
• 12.6. Drivers and Restraints - Impact Analysis
• 12.7. Key Players - Intensity Mapping
• 12.8. Country Level Analysis & Forecast
  • 12.8.1. U.S. Market
    • 12.8.1.1. Introduction
    • 12.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 12.8.1.2.1. By Product
      • 12.8.1.2.2. By Application
      • 12.8.1.2.3. By End User
  • 12.8.2. Canada Market
    • 12.8.2.1. Introduction
    • 12.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 12.8.2.2.1. By Product
      • 12.8.2.2.2. By Application
      • 12.8.2.2.3. By End User

13. Latin America Market Analysis 2019-2023 and Forecast 2024-2033

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 13.3.1. By Country
    • 13.3.1.1. Brazil
    • 13.3.1.2. Argentina
    • 13.3.1.3. Mexico
    • 13.3.1.4. Rest of Latin America
  • 13.3.2. By Product
  • 13.3.3. By Application
  • 13.3.4. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Product
  • 13.4.3. By Application
  • 13.4.4. By End User
• 13.5. Key Market Trends
• 13.6. Drivers and Restraints - Impact Analysis
• 13.7. Key Players - Intensity Mapping
• 13.8. Country Level Analysis & Forecast
  • 13.8.1. Brazil Market
    • 13.8.1.1. Introduction
    • 13.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.1.2.1. By Product
      • 13.8.1.2.2. By Application
      • 13.8.1.2.3. By End User
  • 13.8.2. Argentina Market
    • 13.8.2.1. Introduction
    • 13.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.2.2.1. By Product
      • 13.8.2.2.2. By Application
      • 13.8.2.2.3. By End User
  • 13.8.3. Mexico Market
    • 13.8.3.1. Introduction
    • 13.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 13.8.3.2.1. By Product
      • 13.8.3.2.2. By Application
      • 13.8.3.2.3. By End User

14. East Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 14.3.1. By Country
    • 14.3.1.1. China
    • 14.3.1.2. Japan
    • 14.3.1.3. South Korea
  • 14.3.2. By Product
  • 14.3.3. By Application
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Product
  • 14.4.3. By Application
  • 14.4.4. By End User
• 14.5. Key Market Trends
• 14.6. Drivers and Restraints - Impact Analysis
• 14.7. Key Players - Intensity Mapping
• 14.8. Country Level Analysis & Forecast
  • 14.8.1. China Market
    • 14.8.1.1. Introduction
    • 14.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.1.2.1. By Product
      • 14.8.1.2.2. By Application
      • 14.8.1.2.3. By End User
  • 14.8.2. Japan Market
    • 14.8.2.1. Introduction
    • 14.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.2.2.1. By Product
      • 14.8.2.2.2. By Application
      • 14.8.2.2.3. By End User
  • 14.8.3. South Korea Market
    • 14.8.3.1. Introduction
    • 14.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.8.3.2.1. By Product
      • 14.8.3.2.2. By Application
      • 14.8.3.2.3. By End User

15. South Asia & Pacific Market Analysis 2019-2023 and Forecast 2024-2033

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 15.3.1. By Country
    • 15.3.1.1. India
    • 15.3.1.2. Indonesia
    • 15.3.1.3. Thailand
    • 15.3.1.4. Philippines
    • 15.3.1.5. Malaysia
    • 15.3.1.6. Vietnam
    • 15.3.1.7. Rest of ASEAN
    • 15.3.1.8. Australia & New Zealand
  • 15.3.2. By Product
  • 15.3.3. By Application
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Product
  • 15.4.3. By Application
  • 15.4.4. By End User
• 15.5. Key Market Trends
• 15.6. Drivers and Restraints - Impact Analysis
• 15.7. Key Players - Intensity Mapping
• 15.8. Country Level Analysis & Forecast
  • 15.8.1. India Market
    • 15.8.1.1. Introduction
    • 15.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.1.2.1. By Product
      • 15.8.1.2.2. By Application
      • 15.8.1.2.3. By End User
  • 15.8.2. Indonesia Market
    • 15.8.2.1. Introduction
    • 15.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.2.2.1. By Product
      • 15.8.2.2.2. By Application
      • 15.8.2.2.3. By End User
  • 15.8.3. Thailand Market
    • 15.8.3.1. Introduction
    • 15.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.3.2.1. By Product
      • 15.8.3.2.2. By Application
      • 15.8.3.2.3. By End User
  • 15.8.4. Philippines Market
    • 15.8.4.1. Introduction
    • 15.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.4.2.1. By Product
      • 15.8.4.2.2. By Application
      • 15.8.4.2.3. By End User
  • 15.8.5. Malaysia Market
    • 15.8.5.1. Introduction
    • 15.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.5.2.1. By Product
      • 15.8.5.2.2. By Application
      • 15.8.5.2.3. By End User
  • 15.8.6. Vietnam Market
    • 15.8.6.1. Introduction
    • 15.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.6.2.1. By Product
      • 15.8.6.2.2. By Application
      • 15.8.6.2.3. By End User
  • 15.8.7. Australia & New Zealand Market
    • 15.8.7.1. Introduction
    • 15.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 15.8.7.2.1. By Product
      • 15.8.7.2.2. By Application
      • 15.8.7.2.3. By End User

16. Western Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 16.3.1. By Country
    • 16.3.1.1. Germany
    • 16.3.1.2. France
    • 16.3.1.3. Spain
    • 16.3.1.4. Italy
    • 16.3.1.5. BENELUX
    • 16.3.1.6. Nordic Countries
    • 16.3.1.7. United Kingdom
  • 16.3.2. By Product
  • 16.3.3. By Application
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Product
  • 16.4.3. By Application
  • 16.4.4. By End User
• 16.5. Key Market Trends
• 16.6. Drivers and Restraints - Impact Analysis
• 16.7. Key Players - Intensity Mapping
• 16.8. Country Level Analysis & Forecast
  • 16.8.1. Germany Market
    • 16.8.1.1. Introduction
    • 16.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.1.2.1. By Product
      • 16.8.1.2.2. By Application
      • 16.8.1.2.3. By End User
  • 16.8.2. France Market
    • 16.8.2.1. Introduction
    • 16.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.2.2.1. By Product
      • 16.8.2.2.2. By Application
      • 16.8.2.2.3. By End User
  • 16.8.3. Spain Market
    • 16.8.3.1. Introduction
    • 16.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.3.2.1. By Product
      • 16.8.3.2.2. By Application
      • 16.8.3.2.3. By End User
  • 16.8.4. Italy Market
    • 16.8.4.1. Introduction
    • 16.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.4.2.1. By Product
      • 16.8.4.2.2. By Application
      • 16.8.4.2.3. By End User
  • 16.8.5. BENULUX Market
    • 16.8.5.1. Introduction
    • 16.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.5.2.1. By Product
      • 16.8.5.2.2. By Application
      • 16.8.5.2.3. By End User
  • 16.8.6. Nordic Countries Market
    • 16.8.6.1. Introduction
    • 16.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.6.2.1. By Product
      • 16.8.6.2.2. By Application
      • 16.8.6.2.3. By End User
  • 16.8.7. U.K. Market
    • 16.8.7.1. Introduction
    • 16.8.7.2. Market Analysis and Forecast by Market Taxonomy
      • 16.8.7.2.1. By Product
      • 16.8.7.2.2. By Application
      • 16.8.7.2.3. By End User

17. Eastern Europe Market Analysis 2019-2023 and Forecast 2024-2033

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 17.3.1. By Country
    • 17.3.1.1. Poland
    • 17.3.1.2. Hungary
    • 17.3.1.3. Romania
    • 17.3.1.4. Czech Republic
    • 17.3.1.5. Rest of Eastern Europe
  • 17.3.2. By Product
  • 17.3.3. By Application
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Product
  • 17.4.3. By Application
  • 17.4.4. By End User
• 17.5. Key Market Trends
• 17.6. Drivers and Restraints - Impact Analysis
• 17.7. Key Players - Intensity Mapping
• 17.8. Country Level Analysis & Forecast
  • 17.8.1. Poland Market
    • 17.8.1.1. Introduction
    • 17.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.1.2.1. By Product
      • 17.8.1.2.2. By Application
      • 17.8.1.2.3. By End User
  • 17.8.2. Hungary Market
    • 17.8.2.1. Introduction
    • 17.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.2.2.1. By Product
      • 17.8.2.2.2. By Application
      • 17.8.2.2.3. By End User
  • 17.8.3. Romania Market
    • 17.8.3.1. Introduction
    • 17.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.3.2.1. By Product
      • 17.8.3.2.2. By Application
      • 17.8.3.2.3. By End User
  • 17.8.4. Czech Republic Market
    • 17.8.4.1. Introduction
    • 17.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 17.8.4.2.1. By Product
      • 17.8.4.2.2. By Application
      • 17.8.4.2.3. By End User

18. Central Asia Market Analysis 2019-2023 and Forecast 2024-2033

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 18.3.1. By Product
  • 18.3.2. By Application
  • 18.3.3. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Product
  • 18.4.2. By Application
  • 18.4.3. By End User
• 18.5. Key Market Trends
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Key Players - Intensity Mapping

19. Russia & Belarus Market Analysis 2019-2023 and Forecast 2024-2033

• 19.1. Introduction
• 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 19.3.1. By Product
  • 19.3.2. By Application
  • 19.3.3. By End User
• 19.4. Market Attractiveness Analysis
  • 19.4.1. By Product
  • 19.4.2. By Application
  • 19.4.3. By End User
• 19.5. Key Market Trends
• 19.6. Drivers and Restraints - Impact Analysis
• 19.7. Key Players - Intensity Mapping

20. Balkan & Baltic Countries Market Analysis 2019-2023 and Forecast 2024-2033

• 20.1. Introduction
• 20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 20.3.1. By Product
  • 20.3.2. By Application
  • 20.3.3. By End User
• 20.4. Market Attractiveness Analysis
  • 20.4.1. By Product
  • 20.4.2. By Application
  • 20.4.3. By End User
• 20.5. Key Market Trends
• 20.6. Drivers and Restraints - Impact Analysis
• 20.7. Key Players - Intensity Mapping

21. Middle East and Africa (MEA) Market Analysis 2019-2023 and Forecast 2024-2033

• 21.1. Introduction
• 21.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2019-2023
• 21.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2024-2033
  • 21.3.1. By Country
    • 21.3.1.1. GCC Countries
    • 21.3.1.2. Kingdom of Saudi Arabia
    • 21.3.1.3. Turkiye
    • 21.3.1.4. Northern Africa
    • 21.3.1.5. South Africa
    • 21.3.1.6. Israel
  • 21.3.2. By Product
  • 21.3.3. By Application
  • 21.3.4. By End User
• 21.4. Market Attractiveness Analysis
  • 21.4.1. By Country
  • 21.4.2. By Product
  • 21.4.3. By Application
  • 21.4.4. By End User
• 21.5. Key Market Trends
• 21.6. Drivers and Restraints - Impact Analysis
• 21.7. Key Players - Intensity Mapping
• 21.8. Country Level Analysis & Forecast
  • 21.8.1. GCC Countries Market
    • 21.8.1.1. Introduction
    • 21.8.1.2. Market Analysis and Forecast by Market Taxonomy
      • 21.8.1.2.1. By Product
      • 21.8.1.2.2. By Application
      • 21.8.1.2.3. By End User
  • 21.8.2. Kingdom of Saudi Arabia Market
    • 21.8.2.1. Introduction
    • 21.8.2.2. Market Analysis and Forecast by Market Taxonomy
      • 21.8.2.2.1. By Product
      • 21.8.2.2.2. By Application
      • 21.8.2.2.3. By End User
  • 21.8.3. Turkiye Market
    • 21.8.3.1. Introduction
    • 21.8.3.2. Market Analysis and Forecast by Market Taxonomy
      • 21.8.3.2.1. By Product
      • 21.8.3.2.2. By Application
      • 21.8.3.2.3. By End User
  • 21.8.4. Northern Africa Market
    • 21.8.4.1. Introduction
    • 21.8.4.2. Market Analysis and Forecast by Market Taxonomy
      • 21.8.4.2.1. By Product
      • 21.8.4.2.2. By Application
      • 21.8.4.2.3. By End User
  • 21.8.5. South Africa Market
    • 21.8.5.1. Introduction
    • 21.8.5.2. Market Analysis and Forecast by Market Taxonomy
      • 21.8.5.2.1. By Product
      • 21.8.5.2.2. By Application
      • 21.8.5.2.3. By End User
  • 21.8.6. Israel Market
    • 21.8.6.1. Introduction
    • 21.8.6.2. Market Analysis and Forecast by Market Taxonomy
      • 21.8.6.2.1. By Product
      • 21.8.6.2.2. By Application
      • 21.8.6.2.3. By End User

22. Market Structure Analysis

• 22.1. Market Analysis by Tier of Companies
• 22.2. Market Share Analysis of Top Players
• 22.3. Market Presence Analysis
  • 22.3.1. Regional footprint of Players
  • 22.3.2. Platform Type foot print by Players
  • 22.3.3. Channel Foot Print by Players

23. Competition Analysis

• 23.1. Competition Dashboard
• 23.2. Competition Benchmarking
• 23.3. Competition Deep Dive
  • 23.3.1. Eli Lilly and Company
    • 23.3.1.1. Company Overview
    • 23.3.1.2. Product Portfolio
    • 23.3.1.3. Sales Footprint
    • 23.3.1.4. Key Financials
    • 23.3.1.5. SWOT Analysis
    • 23.3.1.6. Key Developments
    • 23.3.1.7. Strategy Overview
      • 23.3.1.7.1. Channel Strategy
      • 23.3.1.7.2. Marketing Strategy
      • 23.3.1.7.3. Product Strategy
  • 23.3.2. Blue Earth Diagnostics
    • 23.3.2.1. Company Overview
    • 23.3.2.2. Product Portfolio
    • 23.3.2.3. Sales Footprint
    • 23.3.2.4. Key Financials
    • 23.3.2.5. SWOT Analysis
    • 23.3.2.6. Key Developments
    • 23.3.2.7. Strategy Overview
      • 23.3.2.7.1. Channel Strategy
      • 23.3.2.7.2. Marketing Strategy
      • 23.3.2.7.3. Product Strategy
  • 23.3.3. Lantheus
    • 23.3.3.1. Company Overview
    • 23.3.3.2. Product Portfolio
    • 23.3.3.3. Sales Footprint
    • 23.3.3.4. Key Financials
    • 23.3.3.5. SWOT Analysis
    • 23.3.3.6. Key Developments
    • 23.3.3.7. Strategy Overview
      • 23.3.3.7.1. Channel Strategy
      • 23.3.3.7.2. Marketing Strategy
      • 23.3.3.7.3. Product Strategy
  • 23.3.4. Siemens Healthcare Private Limited
    • 23.3.4.1. Company Overview
    • 23.3.4.2. Product Portfolio
    • 23.3.4.3. Sales Footprint
    • 23.3.4.4. Key Financials
    • 23.3.4.5. SWOT Analysis
    • 23.3.4.6. Key Developments
    • 23.3.4.7. Strategy Overview
      • 23.3.4.7.1. Channel Strategy
      • 23.3.4.7.2. Marketing Strategy
      • 23.3.4.7.3. Product Strategy
  • 23.3.5. GE Healthcare
    • 23.3.5.1. Company Overview
    • 23.3.5.2. Product Portfolio
    • 23.3.5.3. Sales Footprint
    • 23.3.5.4. Key Financials
    • 23.3.5.5. SWOT Analysis
    • 23.3.5.6. Key Developments
    • 23.3.5.7. Strategy Overview
      • 23.3.5.7.1. Channel Strategy
      • 23.3.5.7.2. Marketing Strategy
      • 23.3.5.7.3. Product Strategy
  • 23.3.6. Advanced Accelerator Applications (Novartis)
    • 23.3.6.1. Company Overview
    • 23.3.6.2. Product Portfolio
    • 23.3.6.3. Sales Footprint
    • 23.3.6.4. Key Financials
    • 23.3.6.5. SWOT Analysis
    • 23.3.6.6. Key Developments
    • 23.3.6.7. Strategy Overview
      • 23.3.6.7.1. Channel Strategy
      • 23.3.6.7.2. Marketing Strategy
      • 23.3.6.7.3. Product Strategy
  • 23.3.7. University of Lowa HealthCare
    • 23.3.7.1. Company Overview
    • 23.3.7.2. Product Portfolio
    • 23.3.7.3. Sales Footprint
    • 23.3.7.4. Key Financials
    • 23.3.7.5. SWOT Analysis
    • 23.3.7.6. Key Developments
    • 23.3.7.7. Strategy Overview
      • 23.3.7.7.1. Channel Strategy
      • 23.3.7.7.2. Marketing Strategy
      • 23.3.7.7.3. Product Strategy
  • 23.3.8. Telix Pharmaceuticals Limited
    • 23.3.8.1. Company Overview
    • 23.3.8.2. Product Portfolio
    • 23.3.8.3. Sales Footprint
    • 23.3.8.4. Key Financials
    • 23.3.8.5. SWOT Analysis
    • 23.3.8.6. Key Developments
    • 23.3.8.7. Strategy Overview
      • 23.3.8.7.1. Channel Strategy
      • 23.3.8.7.2. Marketing Strategy
      • 23.3.8.7.3. Product Strategy
  • 23.3.9. Jubilant Radiopharma
    • 23.3.9.1. Company Overview
    • 23.3.9.2. Product Portfolio
    • 23.3.9.3. Sales Footprint
    • 23.3.9.4. Key Financials
    • 23.3.9.5. SWOT Analysis
    • 23.3.9.6. Key Developments
    • 23.3.9.7. Strategy Overview
      • 23.3.9.7.1. Channel Strategy
      • 23.3.9.7.2. Marketing Strategy
      • 23.3.9.7.3. Product Strategy
  • 23.3.10. TRASIS
    • 23.3.10.1. Company Overview
    • 23.3.10.2. Product Portfolio
    • 23.3.10.3. Sales Footprint
    • 23.3.10.4. Key Financials
    • 23.3.10.5. SWOT Analysis
    • 23.3.10.6. Key Developments
    • 23.3.10.7. Strategy Overview
      • 23.3.10.7.1. Channel Strategy
      • 23.3.10.7.2. Marketing Strategy
      • 23.3.10.7.3. Product Strategy
  • 23.3.11. RadioMedix Inc.
    • 23.3.11.1. Company Overview
    • 23.3.11.2. Product Portfolio
    • 23.3.11.3. Sales Footprint
    • 23.3.11.4. Key Financials
    • 23.3.11.5. SWOT Analysis
    • 23.3.11.6. Key Developments
    • 23.3.11.7. Strategy Overview
      • 23.3.11.7.1. Channel Strategy
      • 23.3.11.7.2. Marketing Strategy
      • 23.3.11.7.3. Product Strategy
  • 23.3.12. IBA Radiopharma Solutions
    • 23.3.12.1. Company Overview
    • 23.3.12.2. Product Portfolio
    • 23.3.12.3. Sales Footprint
    • 23.3.12.4. Key Financials
    • 23.3.12.5. SWOT Analysis
    • 23.3.12.6. Key Developments
    • 23.3.12.7. Strategy Overview
      • 23.3.12.7.1. Channel Strategy
      • 23.3.12.7.2. Marketing Strategy
      • 23.3.12.7.3. Product Strategy
  • 23.3.13. Piramal Imaging (Life Molecular Imaging)
    • 23.3.13.1. Company Overview
    • 23.3.13.2. Product Portfolio
    • 23.3.13.3. Sales Footprint
    • 23.3.13.4. Key Financials
    • 23.3.13.5. SWOT Analysis
    • 23.3.13.6. Key Developments
    • 23.3.13.7. Strategy Overview
      • 23.3.13.7.1. Channel Strategy
      • 23.3.13.7.2. Marketing Strategy
      • 23.3.13.7.3. Product Strategy
  • 23.3.14. Cardinal Health
    • 23.3.14.1. Company Overview
    • 23.3.14.2. Product Portfolio
    • 23.3.14.3. Sales Footprint
    • 23.3.14.4. Key Financials
    • 23.3.14.5. SWOT Analysis
    • 23.3.14.6. Key Developments
    • 23.3.14.7. Strategy Overview
      • 23.3.14.7.1. Channel Strategy
      • 23.3.14.7.2. Marketing Strategy
      • 23.3.14.7.3. Product Strategy
  • 23.3.15. DuchemBio, Co., Ltd
    • 23.3.15.1. Company Overview
    • 23.3.15.2. Product Portfolio
    • 23.3.15.3. Sales Footprint
    • 23.3.15.4. Key Financials
    • 23.3.15.5. SWOT Analysis
    • 23.3.15.6. Key Developments
    • 23.3.15.7. Strategy Overview
      • 23.3.15.7.1. Channel Strategy
      • 23.3.15.7.2. Marketing Strategy
      • 23.3.15.7.3. Product Strategy

24. Assumptions and Acronyms Used

25. Research Methodology

관련자료